Marc Schlesser

1.6k total citations
26 papers, 828 citations indexed

About

Marc Schlesser is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Marc Schlesser has authored 26 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in Marc Schlesser's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Asthma and respiratory diseases (4 papers) and Respiratory and Cough-Related Research (3 papers). Marc Schlesser is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Asthma and respiratory diseases (4 papers) and Respiratory and Cough-Related Research (3 papers). Marc Schlesser collaborates with scholars based in Belgium, Luxembourg and Switzerland. Marc Schlesser's co-authors include C Frenay, C Boutin, P. Astoul, Walter Vincken, Marc Meysman, Jan DʼHaese, Marc Noppen, Romain Nati, Nico J. Diederich and Giovanna Russo and has published in prestigious journals such as Gut, CHEST Journal and Journal of the American Society of Nephrology.

In The Last Decade

Marc Schlesser

26 papers receiving 795 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Schlesser Belgium 14 501 167 118 98 95 26 828
Joseph A. Golish United States 24 846 1.7× 676 4.0× 68 0.6× 211 2.2× 59 0.6× 63 1.5k
C Sturani Italy 15 754 1.5× 203 1.2× 55 0.5× 88 0.9× 55 0.6× 35 987
Chiara Falcone Italy 18 284 0.6× 67 0.4× 143 1.2× 157 1.6× 93 1.0× 30 1.1k
Dalia Wajsbrot United States 18 367 0.7× 166 1.0× 60 0.5× 163 1.7× 101 1.1× 50 1.2k
Anthony Pereira United Kingdom 16 357 0.7× 54 0.3× 76 0.6× 63 0.6× 305 3.2× 46 990
Robert Fishman United States 14 679 1.4× 246 1.5× 64 0.5× 92 0.9× 72 0.8× 29 1.1k
M. L. Friis Denmark 17 128 0.3× 53 0.3× 53 0.4× 91 0.9× 93 1.0× 43 712
Alessandro Bertaccini Italy 20 669 1.3× 64 0.4× 188 1.6× 313 3.2× 8 0.1× 59 1.2k
Melissa L. Bates United States 19 383 0.8× 101 0.6× 100 0.8× 79 0.8× 12 0.1× 68 809
Nicole Fowler United States 15 141 0.3× 37 0.2× 164 1.4× 151 1.5× 61 0.6× 43 617

Countries citing papers authored by Marc Schlesser

Since Specialization
Citations

This map shows the geographic impact of Marc Schlesser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Schlesser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Schlesser more than expected).

Fields of papers citing papers by Marc Schlesser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Schlesser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Schlesser. The network helps show where Marc Schlesser may publish in the future.

Co-authorship network of co-authors of Marc Schlesser

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Schlesser. A scholar is included among the top collaborators of Marc Schlesser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Schlesser. Marc Schlesser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jason, Leonard A., et al.. (2023). Assessing symptoms of long/post COVID and chronic fatigue syndrome using the DePaul symptom questionnaire-2: a validation in a German-speaking population. Fatigue Biomedicine Health & Behavior. 12(1). 72–90. 1 indexed citations
2.
Wuyts, Wim, Caroline Dahlqvist, Hans Slabbynck, et al.. (2022). Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry. Pulmonary Therapy. 8(2). 181–194. 7 indexed citations
3.
Wuyts, Wim, Caroline Dahlqvist, Hans Slabbynck, et al.. (2019). Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry. Respiratory Research. 20(1). 231–231. 18 indexed citations
4.
Topalovic, Marko, Nilakash Das, Pierre‐Régis Burgel, et al.. (2019). Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests. European Respiratory Journal. 53(4). 1801660–1801660. 128 indexed citations
5.
Bocquet, Valéry, Jessica Barré, Sophie Couffignal, et al.. (2018). Study design and characteristics of the Luxembourg European Health Examination Survey (EHES-LUX). BMC Public Health. 18(1). 1169–1169. 10 indexed citations
6.
Wuyts, Wim, Caroline Dahlqvist, Hans Slabbynck, et al.. (2018). Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry. BMJ Open Respiratory Research. 5(1). e000331–e000331. 35 indexed citations
7.
Wuyts, Wim, Caroline Dahlqvist, Hans Slabbynck, et al.. (2018). Functional decline over time in patients with IPF treated with pirfenidone: the PROOF registry. PA2201–PA2201. 1 indexed citations
9.
Ninane, Vincent, Jan Vandevoorde, Didier Cataldo, et al.. (2015). New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences. Respiratory Medicine. 109(11). 1430–1438. 26 indexed citations
10.
Kim, Yeoun Jin, Sébastien Gallien, Victoria El‐Khoury, et al.. (2015). Quantification of SAA1 and SAA2 in lung cancer plasma using the isotype‐specific PRM assays. PROTEOMICS. 15(18). 3116–3125. 51 indexed citations
12.
Dyck, Eric Van, Petr V. Nazarov, Arnaud Muller, et al.. (2014). Bronchial airway gene expression in smokers with lung or head and neck cancer. Cancer Medicine. 3(2). 322–336. 13 indexed citations
13.
Ninane, Vincent, Guy Brusselle, Renaud Louis, et al.. (2013). Usage of inhalation devices in asthma and chronic obstructive pulmonary disease: a Delphi consensus statement. Expert Opinion on Drug Delivery. 11(3). 313–323. 11 indexed citations
14.
Diederich, Nico J., et al.. (2005). Sleep apnea syndrome in Parkinson's disease. A case–control study in 49 patients. Movement Disorders. 20(11). 1413–1418. 117 indexed citations
15.
Boutin, C, Marc Schlesser, C Frenay, & P. Astoul. (1998). Malignant pleural mesothelioma. European Respiratory Journal. 12(4). 972–981. 129 indexed citations
16.
Noppen, Marc, Marc Schlesser, Marc Meysman, et al.. (1997). Bronchoscopic Balloon Dilatation in the Combined Management of Postintubation Stenosis of the Trachea in Adults. CHEST Journal. 112(4). 1136–1140. 50 indexed citations
17.
Noppen, Marc, et al.. (1997). Comparison of video-assisted thoracoscopic talcage for recurrent primary versus persistent secondary spontaneous pneumothorax. European Respiratory Journal. 10(2). 412–416. 32 indexed citations
18.
Noppen, Marc, Marc Meysman, Jan DʼHaese, Marc Schlesser, & Walter Vincken. (1997). Interventional Bronchoscopy: 5-Year Experience at the Academic Hospital of the Vrije Universiteit Brussel (AZ-VUB).. Acta Clinica Belgica. 52(6). 371–380. 35 indexed citations
19.
Decaux, Guy, et al.. (1994). Uric acid, anion gap and urea concentration in the diagnostic approach to hyponatremia.. PubMed. 42(2). 102–8. 33 indexed citations
20.
Decaux, Guy, et al.. (1991). Very low blood urea concentration less than 2 mmol l in hyponatremia secondary to polydipsia is associated with low urine osmolality. Journal of the American Society of Nephrology. 2(3). 721. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026